Zymeworks Inc. Common Stock
ZYME
$27.57+2.82%
End of day · as of Sep 23, 2026, 6:30 AM ET
Mkt cap
$1.68B
EV/Sales
15.5
P/E ratio
N/A
FY2025 Revenue
$105.97M
EPS (H1 2026)
$-1.00
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-76.56%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported ZYME revenue for 2025-12-31 was $106.0M. Net income was -$81.1M. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. ZYME currently screens at market cap $1.68B.
Use this ZYME research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ZYME income, balance, and cash tables.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company in the Healthcare sector.
Latest cached Zymeworks Inc. Common Stock (ZYME) revenue for Dec 31, 2025 was $106.0M. Net income was -$81.1M. Statements: https://lician.com/financials/zyme
Zymeworks Inc. Common Stock (ZYME) market capitalization is $1.68B on the latest cached snapshot.
Zymeworks Inc. Common Stock (ZYME) cached previous close $26.81; day range $26.55 – $27.70; volume 445,932. Session quote: https://lician.com/quote/zyme
Zymeworks Inc. Common Stock (ZYME) latest cached earnings event is "ZYME earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ZYME filing is 8-K · Sep 23, 2026. Filings: https://lician.com/sec/zyme